omega-n-methylarginine has been researched along with 1-(2-trifluoromethylphenyl)imidazole in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (1-(2-trifluoromethylphenyl)imidazole) | Trials (1-(2-trifluoromethylphenyl)imidazole) | Recent Studies (post-2010) (1-(2-trifluoromethylphenyl)imidazole) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 76 | 0 | 20 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chemtob, S; Dumont, I; Hardy, P; Hou, X; Nuyt, AM; Peri, KG; Varma, DR | 1 |
1 other study(ies) available for omega-n-methylarginine and 1-(2-trifluoromethylphenyl)imidazole
| Article | Year |
|---|---|
Developmentally increased cerebrovascular NO in newborn pigs curtails cerebral blood flow autoregulation.
Topics: Animals; Animals, Newborn; Blood Pressure; Brain; Cerebrovascular Circulation; Enzyme Inhibitors; Homeostasis; Imidazoles; Indazoles; Microcirculation; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Swine | 1999 |